| Date Filed | Type | Description |
| 09/29/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 09/29/2023 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 01/30/2023 |
3
| aMoon Growth Fund Limited Partnership (10% Owner) has filed a Form 3 on Ayala Pharmaceuticals, Inc. |
| 01/23/2023 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 46 shares
@ $0
Granted 2,342 options
@ $55.23, valued at
$129.3k
Granted 2,342 options
@ $8.7, valued at
$20.4k
|
|
| 01/23/2023 |
4
| GOLDBERG MURRAY A (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 3,279 options
@ $27.21, valued at
$89.2k
Granted 2,342 options
@ $47.17, valued at
$110.5k
Granted 1,171 options
@ $55.23, valued at
$64.7k
Granted 1,171 options
@ $8.7, valued at
$10.2k
|
|
| 01/23/2023 |
4
| Bisker-Leib Vered (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 1,639 options
@ $58.59, valued at
$96k
Granted 1,171 options
@ $55.23, valued at
$64.7k
Granted 1,171 options
@ $8.69, valued at
$10.2k
|
|
| 01/23/2023 |
4
| Spiegel Robert J. (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 3,279 options
@ $27.21, valued at
$89.2k
Granted 2,342 options
@ $47.17, valued at
$110.5k
Granted 1,171 options
@ $55.23, valued at
$64.7k
Granted 1,171 options
@ $8.7, valued at
$10.2k
|
|
| 01/23/2023 |
3
| GOLDBERG MURRAY A (Director) has filed a Form 3 on Ayala Pharmaceuticals, Inc. |
| 01/23/2023 |
3
| Bisker-Leib Vered (Director) has filed a Form 3 on Ayala Pharmaceuticals, Inc. |
| 01/23/2023 |
3
| Spiegel Robert J. (Director) has filed a Form 3 on Ayala Pharmaceuticals, Inc. |
| 02/16/2021 |
3
| Gitelman Igor (Chief Accounting Officer) has filed a Form 3 on Advaxis, Inc. |
| 05/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2020 |
4
| APPEL RONI (Director) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Sold 399 shares
@ $0.67, valued at
$267.3
Sold 200 shares
@ $0.58, valued at
$116
Sold 2,401 shares
@ $0.55, valued at
$1.3k
|
|
| 10/25/2019 |
4
| Gutierrez Andres (Exec VP, Chief Medical Officer) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 25,000 options
@ $0.31, valued at
$7.8k
|
|
| 10/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2019 |
4
| Henderson Molly (Executive Vice President & CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 25,000 options
@ $0.31, valued at
$7.8k
|
|
| 10/25/2019 |
4
| APPEL RONI (Director) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 10,000 options
@ $0.31, valued at
$3.1k
|
|
| 10/25/2019 |
4
| Khleif Samir N (Director) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 10,000 options
@ $0.31, valued at
$3.1k
|
|
| 10/25/2019 |
4
| Berlin Kenneth A (President & CEO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 50,000 options
@ $0.31, valued at
$15.5k
|
|
| 10/25/2019 |
4
| PATTON JAMES P (Director) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 10,000 options
@ $0.31, valued at
$3.1k
|
|
| 04/11/2019 |
4
| Gutierrez Andres (Executive Vice President & CMO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 3,750 shares
@ $3.7142, valued at
$13.9k
|
|
| 04/11/2019 |
4
| APPEL RONI (Director) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Bought 3,000 shares
@ $3.797, valued at
$11.4k
|
|
| 04/11/2019 |
4
| Henderson Molly (Executive Vice President & CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 2,500 shares
@ $3.6799, valued at
$9.2k
|
|
| 04/10/2019 |
4
| Henderson Molly (Executive Vice President & CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 2,900 shares
@ $3.8599, valued at
$11.2k
Granted 100 shares
@ $3.85, valued at
$385 |
|
| 04/08/2019 |
4
| Berlin Kenneth A (President & CEO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 1,100 shares
@ $3.775, valued at
$4.2k
Granted 2,100 shares
@ $3.779, valued at
$7.9k
Granted 800 shares
@ $3.78, valued at
$3k
|
|
| 11/07/2018 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 30,000 options
@ $0.54, valued at
$16.2k
|
|
|